European biotechs Morphosys and Galapagos have handed over their joint atopical dermatitis programme MOR106 to...
Up To Date
Latest News
The Innovative Medicines Initiative has launched a new Antimicrobial Resistance Accelerator Programme after...
Roche announced today that the US-American Food and Drug Administration FDA has granted Breakthrough Therapy...
UK biotech Oxford BioDynamics has presented data showing that the company’s blood test can predict patient...
Swiss biopharma company Urovant Sciences has launched its IPO on Nasdaq, seeking US$150m. The proceeds will go...
Danish Genmab and German Immatics Biotechnologies are collaborating to discover and develop next-generation...
Share
